Literature DB >> 758679

Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity.

P D Scanlon, F A Raymond, R M Weinshilboum.   

Abstract

Low catechol-O-methyltransferase (COMT) activity (less than 8 units per milliliter) in the human erythrocyte is inherited as an autosomal recessive trait (COMTL). The average half-life of COMT in erythrocyte lysates incubated at 48 degrees C was significantly shorter in lysates from three subjects with low enzyme activity than in lysates from three subjects with high enzyme activity (12.5 +/- 0.9 minutes compared with 21.2 +/- 1.4 minutes, P less than .01). When the ratios of COMT activities in lysates heated at 48 degrees C for 15 minutes to enzyme activities in unheated samples were used as a measure of enzyme thermostability in blood samples from 316 randomly selected subjects, the ratios were significantly less for subjects with low enzyme activity than for subjects with higher enzyme activity. The presense of thermolabile COMT in blood of individuals homozygous for COMTL raises the possibility that the locus COMT may represent the structural gene for the human enzyme.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 758679     DOI: 10.1126/science.758679

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  42 in total

Review 1.  Genetics of emotion.

Authors:  Laura Bevilacqua; David Goldman
Journal:  Trends Cogn Sci       Date:  2011-08-10       Impact factor: 20.229

2.  The genetic basis of addictive disorders.

Authors:  Francesca Ducci; David Goldman
Journal:  Psychiatr Clin North Am       Date:  2012-06

3.  Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response.

Authors:  Y Ji; J Biernacka; K Snyder; M Drews; L L Pelleymounter; C Colby; L Wang; D A Mrazek; R M Weinshilboum
Journal:  Pharmacogenomics J       Date:  2010-09-28       Impact factor: 3.550

Review 4.  Genetic approaches to addiction: genes and alcohol.

Authors:  Francesca Ducci; David Goldman
Journal:  Addiction       Date:  2008-04-16       Impact factor: 6.526

5.  Morphological changes in gray matter volume correlate with catechol-O-methyl transferase gene Val158Met polymorphism in first-episode treatment-naïve patients with schizophrenia.

Authors:  Ming-Li Li; Bo Xiang; Yin-Fei Li; Xun Hu; Qiang Wang; Wan-Jun Guo; Wei Lei; Chao-Hua Huang; Lian-Sheng Zhao; Na Li; Hong-Yan Ren; Hui-Yao Wang; Xiao-Hong Ma; Wei Deng; Tao Li
Journal:  Neurosci Bull       Date:  2015-01-06       Impact factor: 5.203

Review 6.  Pharmacogenomics: catechol O-methyltransferase to thiopurine S-methyltransferase.

Authors:  Richard M Weinshilboum
Journal:  Cell Mol Neurobiol       Date:  2006-06-29       Impact factor: 5.046

7.  Catechol-O-methyltransferase: effects of the val108met polymorphism on protein turnover in human cells.

Authors:  Anne E Doyle; James D Yager
Journal:  Biochim Biophys Acta       Date:  2007-10-16

8.  Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase (MAO): possible linkage between the ABO locus and a gene controlling DBH activity.

Authors:  L R Goldin; E S Gershon; C R Lake; D L Murphy; M McGinniss; R S Sparkes
Journal:  Am J Hum Genet       Date:  1982-03       Impact factor: 11.025

9.  A Randomized Controlled Trial of Green Tea Extract Supplementation and Mammographic Density in Postmenopausal Women at Increased Risk of Breast Cancer.

Authors:  Hamed Samavat; Giske Ursin; Tim H Emory; Eunjung Lee; Renwei Wang; Carolyn J Torkelson; Allison M Dostal; Karen Swenson; Chap T Le; Chung S Yang; Mimi C Yu; Douglas Yee; Anna H Wu; Jian-Min Yuan; Mindy S Kurzer
Journal:  Cancer Prev Res (Phila)       Date:  2017-09-13

10.  Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.

Authors:  R M Weinshilboum; S L Sladek
Journal:  Am J Hum Genet       Date:  1980-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.